Header Logo

BROOK DANBOISE

Concepts (73)

Back to Profile
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.


Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Intensive Care Units
1
2022
525
0.570
 Why?
Emergency Service, Hospital
4
2025
1171
0.520
 Why?
Diarrhea
2
2020
331
0.260
 Why?
Emergency Medicine
2
2025
163
0.250
 Why?
Neurologists
1
2025
27
0.230
 Why?
Tissue Plasminogen Activator
1
2025
121
0.220
 Why?
Fibrinolytic Agents
1
2025
207
0.210
 Why?
Thrombolytic Therapy
1
2025
216
0.200
 Why?
HIV Infections
3
2021
2050
0.190
 Why?
Shigella
1
2020
4
0.170
 Why?
Enteropathogenic Escherichia coli
1
2020
6
0.170
 Why?
Campylobacter
1
2020
20
0.170
 Why?
Salmonella
1
2020
29
0.170
 Why?
Drug Resistance, Microbial
1
2020
197
0.160
 Why?
Physicians
2
2024
640
0.160
 Why?
Genes, Bacterial
1
2020
217
0.160
 Why?
Physician-Patient Relations
1
2023
447
0.150
 Why?
Telemedicine
1
2025
506
0.150
 Why?
Dried Blood Spot Testing
1
2018
26
0.150
 Why?
Military Personnel
2
2017
203
0.140
 Why?
Anti-HIV Agents
1
2021
348
0.140
 Why?
Mycoplasma genitalium
1
2017
4
0.140
 Why?
Mycoplasma Infections
1
2017
10
0.140
 Why?
HIV-1
1
2021
484
0.140
 Why?
Specimen Handling
1
2018
151
0.140
 Why?
Levofloxacin
1
2017
47
0.140
 Why?
HIV
1
2018
190
0.130
 Why?
Travel
1
2017
124
0.130
 Why?
Sexually Transmitted Diseases
1
2017
95
0.130
 Why?
Anti-Bacterial Agents
2
2020
2553
0.080
 Why?
Retrospective Studies
1
2022
17391
0.050
 Why?
Mental Recall
1
2024
143
0.050
 Why?
Radiation Dosage
1
2023
146
0.050
 Why?
Drug Resistance, Viral
1
2021
50
0.040
 Why?
Uganda
1
2021
97
0.040
 Why?
Cohort Studies
2
2021
5173
0.040
 Why?
Viral Load
1
2021
408
0.040
 Why?
Adult
4
2024
31600
0.040
 Why?
Humans
8
2025
132201
0.040
 Why?
HIV Antigens
1
2018
12
0.040
 Why?
Immunoenzyme Techniques
1
2018
249
0.040
 Why?
Middle Aged
3
2025
29007
0.040
 Why?
HIV Antibodies
1
2018
71
0.040
 Why?
Protein Stability
1
2018
168
0.040
 Why?
AIDS Serodiagnosis
1
2018
56
0.040
 Why?
Djibouti
1
2017
2
0.040
 Why?
Afghanistan
1
2017
16
0.040
 Why?
Loperamide
1
2017
8
0.040
 Why?
Honduras
1
2017
26
0.030
 Why?
Kenya
1
2017
58
0.030
 Why?
Temperature
1
2018
302
0.030
 Why?
Azithromycin
1
2017
43
0.030
 Why?
Pharynx
1
2017
66
0.030
 Why?
HIV Seropositivity
1
2018
128
0.030
 Why?
Urine
1
2017
91
0.030
 Why?
Rectum
1
2017
114
0.030
 Why?
Escherichia coli Infections
1
2017
192
0.030
 Why?
Male
4
2025
64979
0.030
 Why?
Tomography, X-Ray Computed
1
2023
2165
0.030
 Why?
Female
4
2025
70754
0.030
 Why?
Acute Disease
1
2017
1163
0.030
 Why?
Prospective Studies
1
2025
6569
0.030
 Why?
Drug Therapy, Combination
1
2017
1177
0.030
 Why?
Double-Blind Method
1
2017
1653
0.030
 Why?
Sensitivity and Specificity
1
2018
2138
0.030
 Why?
Surveys and Questionnaires
1
2023
3995
0.020
 Why?
Escherichia coli
1
2017
995
0.020
 Why?
Reproducibility of Results
1
2018
3015
0.020
 Why?
Time Factors
1
2018
6452
0.020
 Why?
Mutation
1
2021
6243
0.020
 Why?
Aged
1
2025
21456
0.020
 Why?
Young Adult
1
2017
9965
0.010
 Why?
Treatment Outcome
1
2017
13028
0.010
 Why?
DANBOISE's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (73)
Explore
_
Similar People (60)
Explore
_
Same Department Expand Description
Explore
_